| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $6.41 | $5.36 | $5.03 | $4.84 | $4.70 | $3.17 | $3.57 | $3.16 |
| EPS (Diluted) | $6.41 | $5.36 | $5.03 | $4.84 | $4.70 | $3.17 | $3.57 | $3.16 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $9.1B | $8.9B | $8.7B | $8.3B | $8.1B | $7.3B | $6.6B | $6.3B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | — | — | $0.1B | $0.1B |
| Total Liabilities | $7.7B | $7.8B | $7.7B | $7.4B | $7.1B | $6.4B | $5.8B | $5.5B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.3B | $1.1B | $1.0B | $0.9B | $0.9B | $0.9B | $0.8B | $0.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | $0.2B | — |
| Investing Cash Flow | $-0.2B | $-0.3B | $-0.4B | $-0.8B | $-0.6B | $-0.6B | $-0.3B | — |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.1B | $0.1B | $0.2B | $0.2B | $0.7B | $0.6B | $0.2B | — |